• Timothy Still was named CEO of Accumetrics (San Diego). Still has been serving as president/COO for the company since earlier this year. Accumetrics specializes in antiplatelet therapies by providing diagnostic tests for rapid platelet function assessment.

• David Marver has been named executive VP/COO of Cardiac Science (Bothell, Washington). Marver spent 14 years at Medtronic, where he held a number of senior leadership positions with large businesses, including cardiac rhythm management, cardiac surgery and diabetes. Cardiac Science makes diagnostic and therapeutic cardiology devices and systems.

• John Kelly, MD, PhD, has been named chief medical officer of Lifeclinic International (Burtonsville, Maryland). Kelly previously was chief health and medical officer of Union Pacific Railroad. Lifeclinic International makes commercial, automated, blood pressure monitors and health stations.

• Mobile Imaging Development (Las Vegas), said that its limited partnership, Mobile Diagnostics Centers, has named Patrick McNamara as CEO. McNamara has been director of marketing and operation of Mobile Diagnostics since June. Mobile Diagnostics Centers provide turn-key mobile imaging services.

• Non-Invasive Monitoring Systems (NIMS; Miami) reported new appointments to its board, including the election of Jane Hsiao, PhD, as chairman. Hsiao, along with Dr. Rao Uppaluri, PhD, and Steven Rubin, were appointed to fill the vacancies created by the resignations of current directors John Clawson, Gerard Kaiser, MD, and Leila Kight. Hsiao has served since May 2007 as vice chairman and chief technical officer of Opko Health, and also serves as chairman of the board of medical device developer SafeStitch Medical. Uppaluri has served as senior VP/CFO of Opko since May 2007 and was a director of the company. Rubin has served as Opko's executive VP of administration since May 2007. NIMS' primary business is the research, development, manufacturing and marketing of the Exer-Rest line of motorized, non-invasive, whole-body, periodic acceleration platforms.